Vimarsana
Biggest News Aggregation in the World

Markus Meile News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Markus Meile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Markus Meile Today - Breaking & Trending Today

MedMira Receives Canadian Patent for its Unique Quantitative Diagnostic System - Vimarsana News

MedMira Receives Canadian Patent for its Unique Quantitative Diagnostic System

HALIFAX, NS / ACCESSWIRE / March 13, 2024 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announces the receipt of a Canadian patent patent (number 2,949,634) for its new innovative and quantitative test system. This is in addition to the U.S. patent (number 11,353,450) received in 2022. Through this new patent, MedMira...

MedMira Reports First Quarter Results FY2024 - Vimarsana News

MedMira Reports First Quarter Results FY2024

MedMira Reports First Quarter Results FY2024

Update on MedMira's Regulatory Path in Canada and the USA | Region - Vimarsana News

Update on MedMira's Regulatory Path in Canada and the USA | Region

HALIFAX, NS / ACCESSWIRE / September 27, 2023 / Today, MedMira Inc. (MedMira) (TSXV:MIR) provides an update on its progress to achieve regulatory approval in Canada and the USA for

MedMira, Inc.: MedMira Reports Second Quarter Results FY2023 - Vimarsana News

MedMira, Inc.: MedMira Reports Second Quarter Results FY2023

HALIFAX, NS / ACCESSWIRE / April 3, 2023 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended January 31, 2023.Corporate Update SummaryDuring the second financial

MedMira, Inc.: Update on MedMira's Reveal TP Clinical Trials in Canada - Vimarsana News

MedMira, Inc.: Update on MedMira's Reveal TP Clinical Trials in Canada

HALIFAX, NS / ACCESSWIRE / March 14, 2023 / Today, MedMira Inc. (MedMira) (TSXV:MIR) provides an update on its progress to achieve regulatory approval in Canada for its Reveal® TP (Syphilis) antibody test.